BNTC
USDBenitec Biopharma Inc. Common Stock
实时价格
价格图表
关键指标
市场指标
开盘价
$15.330
最高价
$15.770
最低价
$14.550
成交量
0.13M
公司基本面
市值
412.4M
所属行业
生物技术
国家/地区
United States
交易统计
平均成交量
0.05M
交易所
NCM
货币
USD
52周价格范围
相关新闻
HC Wainwright & Co. Maintains Buy on Benitec Biopharma, Raises Price Target to $35
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Benitec Biopharma with a Buy and raises the price target from $28 to $35.
Citizens Maintains Market Outperform on Benitec Biopharma, Raises Price Target to $22
Citizens analyst Silvan Tuerkcan maintains Benitec Biopharma with a Market Outperform and raises the price target from $20 to $22.
Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301
Fast Track Designation was granted for BB-301 following FDA review of positive interim clinical study results and proprietary Responder Analysis planned for use in pivotal study for BB-301 BB-301 has also been granted
Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors
HAYWARD, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ:BNTC) ("Benitec" or "Company"), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based
Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy
HAYWARD, Calif., Nov. 02, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ:BNTC) ("Benitec" or the "Company"), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines
相关股票
ADPT
Adaptive Biotechnologies Corporation
UPC
Universe Pharmaceuticals Inc. Ordinary Shares
IGA
Voya Global Advantage and Premium Opportunity Fund Common Shares of Beneficial Interest
MACI
Melar Acquisition Corp. I Ordinary Shares
AGNC
AGNC Investment Corp.
保持更新
设置价格提醒，获取AI分析更新和实时市场新闻。